A mini review of reinfection with the SARS‐CoV‐2 Omicron variant
Health Science Reports,
Journal Year:
2024,
Volume and Issue:
7(4)
Published: April 1, 2024
COVID-19
has
caused
severe
morbidity
and
mortality
worldwide.
After
the
end
of
dynamic
zero-COVID
policy
in
China
December,
2022,
concerns
regarding
reinfection
were
raised
while
little
was
known
due
to
lack
surveillance
data
this
country.
Language: Английский
What is the in-host dynamics of the SARS-CoV-2 virus? A challenge within a multiscale vision of living systems
Networks and Heterogeneous Media,
Journal Year:
2024,
Volume and Issue:
19(2), P. 655 - 681
Published: Jan. 1, 2024
This
paper
deals
with
the
modeling
and
simulation
of
in-host
dynamics
a
virus.
The
approach
was
developed
according
to
idea
that
mathematical
models
should
go
beyond
deterministic
single-scale
population
by
taking
into
account
multiscale,
heterogeneous
features
complex
system
under
consideration.
Here,
we
considered
competition
between
virus,
epithelial
cells
it
infects,
immune
evolving
activation
states
induce
range
different
effects
on
virus
particles
infected
cells.
subsequent
numerical
simulations
showed
types
model
outcomes:
from
elimination,
persistence
periodic
relapse,
uncontrolled
growth
triggers
blow-up
in
fully
activated
response.
also
existence
threshold
response
separates
regimes
higher
re-infections
lower
(compared
magnitude
first
viral
infection).
Language: Английский
Enhancing COVID-19 Vaccination Awareness and Uptake in the Post-PHEIC Era: A Narrative Review of Physician-Level and System-Level Strategies
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(9), P. 1038 - 1038
Published: Sept. 11, 2024
Following
the
World
Health
Organization's
declaration
that
COVID-19
pandemic
is
no
longer
a
public
health
emergency
of
international
concern
(PHEIC),
remains
an
ongoing
threat
to
human
and
healthcare
systems.
Vaccination
plays
crucial
role
in
reducing
disease's
incidence,
mitigating
its
severity,
limiting
transmission,
contributing
long-term
resilience.
However,
incomplete
vaccination
coverage
vaccine
hesitancy
exist.
This
narrative
review
investigates
strategies
at
system
physician
levels
aimed
sustaining
awareness
uptake
post-PHEIC
era.
Through
examination
existing
literature,
this
explores
effectiveness
diverse
approaches
utilized
by
systems
individual
providers.
These
address
every
component
5C
model
hesitancy:
confidence,
complacency,
constraints/convenience,
calculation,
collective
responsibility.
Physician-level
include
appropriate
message
framing,
persuasive
communication
containing
safety
personal/social
benefit
information,
sharing
personal
stories,
creating
safe
space
for
discussion,
harnessing
co-administration
with
annual
influenza
vaccines,
use
decision
aids
visual
messages.
System-level
messaging,
mass
media
communication,
on-site
availability,
pharmacist
delivery,
protocol
integration,
incentives,
chatbot
use.
Language: Английский
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later
Rocío Rubio,
No information about this author
Alexei Yavlinsky,
No information about this author
Marina Escalera Zamudio
No information about this author
et al.
Journal of Infection,
Journal Year:
2024,
Volume and Issue:
unknown, P. 106402 - 106402
Published: Dec. 1, 2024
We
aimed
to
evaluate
the
adaptive
immune
responses'
cross-recognition
of
hypermutated
SARS-CoV-2
BA.2.86
variant
and
identify
determinants
influencing
this
recognition.
Language: Английский
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later
Rocío Rubio,
No information about this author
Alexei Yavlinsky,
No information about this author
Marina Escalera Zamudio
No information about this author
et al.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 9, 2024
Background
The
emergence
of
the
hypermutated
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
BA.2.86
variant
raises
significant
concerns
due
to
its
potential
evade
pre-existing
immunity.
Methods
We
measured
cross-reactivity
neutralizing
antibodies
and
T-cell
responses
in
52
previously
exposed
participants
investigated
clinic-demographic
viral
genetic
determinants
affecting
responses.
Findings
found
that
despite
notable
escape
from
antibodies,
remained
generally
preserved,
albeit
with
a
but
small
loss
cross-recognition
(7.5
%,
14.2
%
10.8
average
for
IFN-g,
IL-2
IFN-g
+
IL-2,
respectively,
p
<
0.05).
This
is
consistent
prediction
6
out
10
immunodominant
epitopes
(TCEs)
altered
by
lineage-defining
mutations
have
reduced
peptide
presentation.
effect
expected
be
mitigated
total
TCEs
across
genome.
Remarkably,
were
3.5
(IFN-g),
(IL-2)
2.4
(IFN-g
IL-2)
times
higher
when
first
induced
natural
infection
rather
than
vaccination
three
years
before,
increasing
number
infections,
ancestral/Delta
Omicron
infections.
Interpretation
Our
findings
underscore
critical
role
factors
influencing
immunity
against
evolving
SARS-CoV-2
variants,
such
as
antigen
encounter
(vaccination
or
infection),
which
essential
developing
effective
control
strategies
variants.
Funding
European
Union
(Horizon
Europe),
Fundacio
Privada
Daniel
Bravo
Andreu,
Catalan
Government
(PERIS,
CERCA),
Spanish
Ministry
Science,
Rosetrees
Trust,
Pears
Foundation.
Language: Английский
COVID-19 pandemic waves and risk of congenital anomalies in the State of Sao Paulo: a population-based cohort study.
Authorea (Authorea),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 29, 2024
Objectives
To
assess
how
the
COVID
outbreak
in
Brazil
might
have
impacted
birth
defects
State
of
São
Paulo.
Design
Population-based
cohort
study.
Setting
The
Paulo,
Brazil.
Population
Births
between
2017
and
2022.
Methods
Exposure
was
determined
by
midpoint
first
trimester.
We
used
a
generalized
linear
model
with
Poisson
distribution
log
link,
clustered
robust
standard
errors.
Municipality
for
clustering.
Main
Outcome
Measures
Relative
Risk
(RR)
any
congenital
anomaly
per
each
anatomical
site.
Results
There
were
2,961,741
cases
analysis.
RR
anomalies
0.97
wave
(95%
CI:
0.95-1.00,
p
=
0.029)
due
to
decrease
respiratory,
genitourinary
central
nervous
system
defects,
pattern
previously
associated
fever-induced
anomalies.
During
third
wave,
there
an
1.08
1.04-1.13,
<
0.001),
increase
cleft
lip
palate,
digestive
circulatory
just
as
severe
food
insecurity
rose.
No
change
risk
identified
during
second
when
both
vaccines
introduced
sales
ivermectin
hydroxychloroquine
spiked.
Conclusions
COVID-19
differently
wave.
Considering
concurrent
conditions
provide
insight
into
underlying
causes
this
phenomenon.
true
burden
pregnant
individuals
supply
chain
disruption,
which
is
also
threatened
climate
change,
not
yet
be
fully
recognized.
Language: Английский
Dynamical systems analysis of a reaction-diffusion SIRS model with optimal control for the COVID-19 spread
Computer Methods in Biomechanics & Biomedical Engineering,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 18
Published: Nov. 13, 2024
We
examine
an
SIRS
reaction-diffusion
model
with
local
dispersal
and
spatial
heterogeneity
to
study
COVID-19
dynamics.
Using
the
operator
semigroup
approach,
we
establish
existence
of
disease-free
equilibrium
(DFE)
endemic
(EE),
derive
basic
reproduction
number,
Language: Английский